Association between the cumulative dose of cyclosporine and liver enzyme abnormalities in dermatology patients managed with a low‐dose regimen
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15855
Abstract: Cyclosporine (CsA) is an immunosuppressive agent that specifically inhibits T cell‐related immune responses. There is little evidence regarding the association between low‐dose CsA administration and abnormal hepatic function in dermatology patients. This study aimed to… read more here.
Keywords: liver enzyme; dose csa; dose; dermatology ... See more keywords
AB0562 LIVER ENZYME ABNORMALITIES IN HOSPITALIZED LUPUS PATIENTS – A RETROSPECTIVE STUDY
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2022-eular.4889
Abstract: Around 25% to 50% of lupus patients may present with alterations in the liver enzymes of variable severity including fulminant hepatic failure.1To study the prevalence, aetiology and the outcome in lupus patients hospitalized with liver… read more here.
Keywords: rheumatology; liver enzyme; enzyme abnormalities; liver enzymes ... See more keywords
State of anxiety may be associated with exocrine pancreatic insufficiency in functional dyspepsia patients with pancreatic enzyme abnormalities
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Biochemistry and Nutrition"
DOI: 10.3164/jcbn.21-67
Abstract: We have reported that refractory functional dyspepsia patients with pancreatic enzyme abnormalities (FD-P). We tried to analyze the prevalence of exocrine pancreatic insufficiency (EPI) in FD-P patients to clarify whether the pathophysiology of FD patients… read more here.
Keywords: functional dyspepsia; pancreatic enzyme; enzyme abnormalities; dyspepsia patients ... See more keywords